MannKind Corporation (MannKind)(consolidare)

Versiunea din 18 septembrie 2024 20:13, autor: Admin (discuție | contribuții) (Pagină nouă: Pagina dedicata companiei MannKind Corporation (MannKind)(consolidare) listata cu simbolul US.MNKDc ==Descriere companie== MannKind Corporation (http://www.mannkindcorp.com) is a biopharmaceutical company. The Company is focused on the development and commercialization of inhaled therapeutic products for diabetes and orphan lung diseases, such as pulmonary arterial hypertension. The Company’s lead product is Afrezza Inhalation Powder, which is an inhaled insulin indicated...)
(dif) ← Versiunea anterioară | Versiunea curentă (dif) | Versiunea următoare → (dif)

Pagina dedicata companiei MannKind Corporation (MannKind)(consolidare) listata cu simbolul US.MNKDc

Descriere companieModificare

MannKind Corporation (http://www.mannkindcorp.com) is a biopharmaceutical company. The Company is focused on the development and commercialization of inhaled therapeutic products for diabetes and orphan lung diseases, such as pulmonary arterial hypertension. The Company’s lead product is Afrezza Inhalation Powder, which is an inhaled insulin indicated to improve glycemic control in adults with diabetes. Afrezza consists of a dry powder formulation of human insulin delivered from a small portable inhaler. AFREZZA utilizes its Technosphere formulation technology. The Technosphere is a drug delivery platform that allow the oral inhalation of a range of therapeutics.

Grafic actiuni companieModificare

Ultimele stiri despre MannKind Corporation (MannKind)(consolidare) (US.MNKDc)Modificare